Xcout Intel
Gate2Brain competitors & alternatives
The 12 closest competitors and alternatives to Gate2Brain among biotechnology companies — ranked by similarity to what Gate2Brain actually does, not by market-cap band.
Subscribe to see Gate2Brain’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Gate2Brain
Gate2Brain is a biotechnology company dedicated to developing therapeutics that can efficiently cross biological barriers, such as the blood-brain barrier. It was founded as a spin-off from IRB Barcelona, the University of Barcelona, and Hospital Sant Joan de Déu.
Gate2Brain at a glance
Gate2Brain is a biotechnology company headquartered in Spain. Its most recent funding round raised $7.7M in June 2026. Xcout tracks 2 named people at Gate2Brain, including Dr. Meritxell Teixidó (CEO CSO).
Gate2Brain leadership
- Dr. Meritxell TeixidóCEO CSO
- Meritxell TeixidóCEO
Gate2Brain funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $7.7M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Gate2Brain news
Top 12 Gate2Brain competitors
Ranked by semantic similarity — how close each company is to Gate2Brain by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Life Sciences
Cajal Neuroscience (Cajal Therapeutics Inc.) is a biotechnology company headquartered in Seattle, Washington. The company is dedicated to advancing therapeutic pipelines in neuroscience research.
Biotech
Gain Therapeutics, Inc. is a biotechnology firm specializing in the creation of advanced treatments for conditions originating from improperly folded proteins. The company primarily directs its efforts towards rare genetic disorders and neurological ailments. It employs its unique Site-Directed Enzyme Enhancement Therapy (SEE-Tx) platform to pinpoint specific allosteric sites on malformed proteins. Subsequently, Gain Therapeutics identifies proprietary small molecules designed to bind to these locations, thereby restoring correct protein conformation and alleviating the disease. Their current development pipeline includes several structurally targeted allosteric regulator candidates aimed at combating a range of diseases, such as Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1. Established in 2017, the company is headquartered in Bethesda, Maryland.
Similar biotechnology company
Dome Therapeutics is a preclinical biotechnology company developing a nanomedicine designed to target brain cancer stem cells that survive standard glioblastoma treatments and drive tumor recurrence. Using a proprietary nanoparticle delivery platform, the company aims to cross the blood-brain barrier to deliver therapeutic payloads directly to these treatment-resistant cells.
Biotech
BrainZell is a Swedish biotechnology company headquartered in Stockholm that develops human brain cell models and patient-relevant brain organoids. Founded in 2020, the company leverages these advanced biological models for AI-native drug discovery to accelerate the development of life-changing therapies.
Biotech
Adaptin Bio is a biotechnology company developing a proprietary drug delivery platform designed to enhance the transfer of therapeutics across biological barriers into the brain and other targeted tissues. Its lead technology, the Brain Bispecific T cell Engager (BRiTE) platform, manipulates the human immune system to target diseases in oncology, central nervous system disorders, autoimmune conditions, and cardiovascular markets.
Biotech
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Biotech
Graph Therapeutics is a next-generation techbio company headquartered in Vienna, Austria. The company is involved in developing advanced therapeutic solutions.
Similar biotechnology company
Irazú Bio partners with academic researchers and university centers to curate and advance translational research assets into IND-enabling studies and Phase 1 clinical trials. The company focuses on areas such as hypoxia tolerance, antiviral formulations, and adeno-associated virus gene therapy, subsequently licensing the developed assets to pharmaceutical companies or forming new ventures with venture capital groups.
Similar biotechnology company
Tolemy Bio is an AI-native virtual cell platform company with operations in Cambridge, United Kingdom, and Barcelona, Spain. The company focuses on virtual cell technologies for therapeutic development and manufacturing.
Biotech
Manifold Biotechnologies, Inc. develops biotechnology solutions for biologic drug discovery and development, specializing in molecular tracking and high-throughput in vivo screening. The company builds an AI-guided direct-to-vivo discovery platform designed to accelerate the development of tissue-targeted medicines, including RNA interference treatments for neurological diseases.
Similar biotechnology company
Alleo Labs is a precision neuroscience company headquartered in San Francisco, California, that re-engineers the treatment of chronic brain disorders by combining computational biology with brain shuttle technology.
Biotech
Verge Genomics develops a proprietary AI and machine learning platform utilizing human brain data to transform neuroscience drug discovery and precision neurology. The company provides foundation models and analytical tools to pharmaceutical and biotechnology developers for target discovery, biomarker identification, and clinical trial patient stratification.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Gate2Brain and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Gate2Brainand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →